| Literature DB >> 29382106 |
Hsiao-Chien Ting1, Chia-Yu Chang2,3, Kang-Yun Lu4,5, Hong-Meng Chuang6,7, Sheng-Feng Tsai8, Mao-Hsuan Huang9,10, Ching-Ann Liu11,12, Shinn-Zong Lin13,14, Horng-Jyh Harn15,16.
Abstract
Traditional Chinese medicine has been practiced for centuries in East Asia. Herbs are used to maintain health and cure disease. Certain Chinese herbs are known to protect and improve the brain, memory, and nervous system. To apply ancient knowledge to modern science, some major natural therapeutic compounds in herbs were extracted and evaluated in recent decades. Emerging studies have shown that herbal compounds have neuroprotective effects or can ameliorate neurodegenerative diseases. To understand the mechanisms of herbal compounds that protect against neurodegenerative diseases, we summarize studies that discovered neuroprotection by herbal compounds and compound-related mechanisms in neurodegenerative disease models. Those compounds discussed herein show neuroprotection through different mechanisms, such as cytokine regulation, autophagy, endoplasmic reticulum (ER) stress, glucose metabolism, and synaptic function. The interleukin (IL)-1β and tumor necrosis factor (TNF)-α signaling pathways are inhibited by some compounds, thus attenuating the inflammatory response and protecting neurons from cell death. As to autophagy regulation, herbal compounds show opposite regulatory effects in different neurodegenerative models. Herbal compounds that inhibit ER stress prevent neuronal death in neurodegenerative diseases. Moreover, there are compounds that protect against neuronal death by affecting glucose metabolism and synaptic function. Since the progression of neurodegenerative diseases is complicated, and compound-related mechanisms for neuroprotection differ, therapeutic strategies may need to involve multiple compounds and consider the type and stage of neurodegenerative diseases.Entities:
Keywords: ER stress; autophagy; cytokine regulation; glucose metabolism; herbal compounds; neurodegenerative disease; neuroprotection agent; synaptic function; traditional Chinese medicine
Mesh:
Substances:
Year: 2018 PMID: 29382106 PMCID: PMC6017457 DOI: 10.3390/molecules23020259
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chinese herbal compound decrease NF-κB activation and cytokines release after ischemia injury.
Figure 2Autophagy regulation by Chinese herb medicine.
Figure 3Schematic representation of the unfolded protein response pathway.
Chinese herbal compounds have neuroprotection ability to various neurological disorders through different mechanisms and metabolisms.
| Herbal Drugs | Plant Sources | Structure | Involved Mechanism (s) | Treated Model | Main Citations |
|---|---|---|---|---|---|
| 6-hydroxycleroda-3,13-dien-15,16-olide (PL3) | cytokine regulation | LPS-induced model | [ | ||
| Ampelopsin | cytokine regulation, autophagy regulation | Stroke, brain aging | [ | ||
| Astragaloside IV | ER stress | PD | [ | ||
| Baicalein | autophagy regulation, ER stress | PD | [ | ||
| Berberine | cytokine regulation, autophagy regulation | depression, AD, and ALS | [ | ||
| Breviscapine | autophagy regulation | cerebral ischemic | [ | ||
| n-butylidenephthalide | autophagy regulation, neurotransmitters and synaptic function | ALS, SCA3, and down syndrome model | [ | ||
| Carnosic acid | autophagy regulation | AD and PD | [ | ||
| Conophylline | autophagy regulation | PD and HD | [ | ||
| Crocin | ER stress | PD and AD | [ | ||
| Cucurbitacin E | autophagy regulation | PD | [ | ||
| Eriodictyol | cytokine regulation | stroke | [ | ||
| Ginsenoside compound K | autophagy regulation | AD | [ | ||
| Ginsenoside Rb1 | autophagy regulation | spinal cord injury | [ | ||
| Hederagenin | autophagy regulation | PD | [ | ||
| Huperzine A | neurotransmitters and synaptic function | AD | [ | ||
| Icariin | cytokine regulation | AD, stroke, depression | [ | ||
| Icariside II | cytokine regulation | AD | [ | ||
| Isobavachalcone | cytokine regulation | PD | [ | ||
| Luteolin | autophagy regulation | AD | [ | ||
| Maslinic acid | glucose metabolism | oxygen-glucose deprivation-induced injury model | [ | ||
| Neferine | autophagy regulation | HD | [ | ||
| Oleuropein | autophagy regulation | PD | [ | ||
| Paeonol | cytokine regulation | PD | [ | ||
| Piperine | autophagy regulation | PD | [ | ||
| Resveratrol | red wine | autophagy regulation, glucose metabolism | AD, PD, HD, and healthy older adults | [ | |
| Ruscogenin | cytokine regulation | Ischemic stroke | [ | ||
| Sulforaphane | autophagy regulation | PD, HD | [ | ||
| Tetrandrine | cytokine regulation | AD | [ | ||
| Thamnolia vermicularis extract | autophagy regulation | AD | [ | ||
| Triptolide | autophagy regulation | AD, PD | [ |
ER, endoplasmic reticulum; LPS, lipopolysaccharide; PD, Parkinson’s disease; AD, Alzheimer’s disease; ALS, amyotrophic lateral sclerosis; SCA3, spinocerebellar ataxia type 3; HD, Huntington disease.